Maria Loose1, Kurt G Naber2, Larry Purcell3, Manfred P Wirth4, Florian M E Wagenlehner5. 1. Clinic for Urology, Paediatric Urology and Andrology, Justus-Liebig University of Giessen, Giessen, Germany, maria.loose@chiru.med.uni-giessen.de. 2. Department of Urology, Technical University of Munich, Munich, Germany. 3. Saxonia R&D, Radeberg, Germany. 4. Department of Urology, Technical University of Dresden, Dresden, Germany. 5. Clinic for Urology, Paediatric Urology and Andrology, Justus-Liebig University of Giessen, Giessen, Germany.
Abstract
BACKGROUND: A catheter allowing a release of antibacterial substances such as antiseptics into the bladder could be a new way of preventing biofilm formation and subsequent catheter-associated urinary tract infections. METHODS: Minimal inhibitory and bactericidal concentration (MIC/MBC) determinations in cation-adjusted Mueller-Hinton broth and artificial urine were performed for 4 antiseptics against 3 uropathogenic biofilm producers, Escherichia coli, Pseudomonas aeruginosa, and Proteus mirabilis. Furthermore, effects of octenidine and polyhexanide against catheter biofilm formation were determined by quantification of biofilm-producing bacteria. RESULTS: Sodium hypochlorite showed MIC/MBC values between 200 and 800 mg/L for all strains tested. Triclosan was efficient against E. coli and P. mirabilis (MIC ≤2.98 mg/L) but ineffective against P. aeruginosa. Octenidine and polyhexanide showed antibacterial activity against all 3 species tested (MIC 1.95-7.8 and 3.9-31.25 mg/L). Both octenidine and polyhexanide were able to prevent biofilm formation on catheter segments in a concentration dependent manner. Furthermore, adding 250 mg/L of each biocide disrupted biofilms formed by E. coli and P. mirabilis, whereas even 500 mg/L was not sufficient to completely destroy P. aeruginosa biofilms. CONCLUSION: Octenidine- and polyhexanide-containing antiseptics showed a broad effect against typical uropathogenic biofilm producers even in high dilutions. This study provides a basis for further investigation of the potential of octenidine and polyhexanide as prophylaxis or treatment of catheter biofilms.
BACKGROUND: A catheter allowing a release of antibacterial substances such as antiseptics into the bladder could be a new way of preventing biofilm formation and subsequent catheter-associated urinary tract infections. METHODS: Minimal inhibitory and bactericidal concentration (MIC/MBC) determinations in cation-adjusted Mueller-Hinton broth and artificial urine were performed for 4 antiseptics against 3 uropathogenic biofilm producers, Escherichia coli, Pseudomonas aeruginosa, and Proteus mirabilis. Furthermore, effects of octenidine and polyhexanide against catheter biofilm formation were determined by quantification of biofilm-producing bacteria. RESULTS:Sodium hypochlorite showed MIC/MBC values between 200 and 800 mg/L for all strains tested. Triclosan was efficient against E. coli and P. mirabilis (MIC ≤2.98 mg/L) but ineffective against P. aeruginosa. Octenidine and polyhexanide showed antibacterial activity against all 3 species tested (MIC 1.95-7.8 and 3.9-31.25 mg/L). Both octenidine and polyhexanide were able to prevent biofilm formation on catheter segments in a concentration dependent manner. Furthermore, adding 250 mg/L of each biocide disrupted biofilms formed by E. coli and P. mirabilis, whereas even 500 mg/L was not sufficient to completely destroy P. aeruginosa biofilms. CONCLUSION:Octenidine- and polyhexanide-containing antiseptics showed a broad effect against typical uropathogenic biofilm producers even in high dilutions. This study provides a basis for further investigation of the potential of octenidine and polyhexanide as prophylaxis or treatment of catheter biofilms.
Authors: Raquel Sopeña-Sutil; José Medina-Polo; Juan Justo-Quintas; Javier Gil-Moradillo; Lucia Garcia-Gonzalez; Raúl Benítez-Sala; Manuel Alonso-Isa; Alba Lara-Isla; Angel Tejido-Sanchez Journal: Urol Int Date: 2018-04-12 Impact factor: 2.089
Authors: Tobias Hirsch; Andreas Koerber; Frank Jacobsen; Joachim Dissemond; Hans-Ulrich Steinau; Sören Gatermann; Sammy Al-Benna; Marco Kesting; Hans-Martin Seipp; Lars Steinstraesser Journal: J Surg Res Date: 2009-05-18 Impact factor: 2.192
Authors: R Pickard; T Lam; G Maclennan; K Starr; M Kilonzo; G McPherson; K Gillies; A McDonald; K Walton; B Buckley; C Glazener; C Boachie; J Burr; J Norrie; L Vale; A Grant; J N'dow Journal: Health Technol Assess Date: 2012-11 Impact factor: 4.014
Authors: Amoolya Narayanan; Meera S Nair; Deepti P Karumathil; Sangeetha A Baskaran; Kumar Venkitanarayanan; Mary Anne Roshni Amalaradjou Journal: Front Microbiol Date: 2016-06-09 Impact factor: 5.640